Budapest, Hungary

János Leibinger


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: János Leibinger: Innovator in Analgesic and Anti-inflammatory Agents

Introduction

János Leibinger is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as analgesic and anti-inflammatory agents. His work is characterized by a commitment to improving treatments for pain and inflammation.

Latest Patents

Leibinger holds a patent for a compound described as 1,2-diaryl pyrazoles, which are useful in treating pain associated with acute and chronic inflammation, postoperative pain, and dysmenorrhea. The patent outlines a novel formula (I) that includes various chemical groups and their stereoisomers, diastereomers, and pharmaceutically acceptable salts. This invention not only details the synthesis process of these compounds but also emphasizes their potential in pharmaceutical compositions aimed at alleviating pain and inflammation.

Career Highlights

János Leibinger is associated with Richter Gedeon Vegyeszeti Gyar Rt, a prominent pharmaceutical company in Hungary. His work at this institution has allowed him to focus on innovative solutions in the pharmaceutical industry, contributing to advancements in pain management and anti-inflammatory treatments.

Collaborations

Throughout his career, Leibinger has collaborated with esteemed colleagues, including János Fischer and Istvánné Kis-Varga. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

János Leibinger's contributions to the field of pharmaceuticals, particularly through his patent for analgesic and anti-inflammatory agents, highlight his role as an innovator. His work continues to impact the treatment of pain and inflammation, showcasing the importance of research and collaboration in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…